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ABSTRACT
PURPOSE: To present a review about a comparative study of bile duct ligation versus carbon tetrachloride Injection for inducing 
experimental liver cirrhosis.
METHODS: This research was made through Medline/PubMed and SciELO web sites looking for papers on the content “induction of 
liver cirrhosis in rats”. We have found 107 articles but only 30 were selected from 2004 to 2011.
RESULTS: The most common methods used for inducing liver cirrhosis in the rat were administration of carbon tetrachloride (CCl4) 
and bile duct ligation (BDL). CCl4 has induced cirrhosis from 36 hours to 18 weeks after injection and BDL from seven days to four 
weeks after surgery. 
CONCLUSION: For a safer inducing cirrhosis method BDL is better than CCl4 because of the absence of toxicity for researches and 
shorter time for achieving it. 
Key words: Liver Cirrhosis. Drugs. Carbon Tetrachloride. Common Bile Duct. Ratos.
RESUMO
OBJETIVO: Apresentar revisão sobre estudo comparativo da indução de cirrose hepática (CH) experimental com a injeção de tetra-
cloreto de carbono (CCl4) comparado à ligadura do ducto biliar (BDL).
MÉTODOS: A pesquisa foi realizada nas bases de dados do Medline/PubMed e SciELO procurando trabalhos com as palavras indução 
de CH e ratos. Foram encontrados 107 artigos, mas somente 30 foram selecionados no período de 2004 à 2011. 
RESULTADOS: Os procedimentos mais comum para indução de CH em ratos foram a injeção de CCl4 e a  BDL. O CCl4 induzia CH 
no período de 36 horas após a injeção e a DBL de sete dias à quatro semanas após a cirurgia.
CONCLUSÃO: A BDL é o método mais seguro para indução de CH quando comparado a injeção de CCl4 pela ausência de toxicidade 
para os pesquisadores e o menor tempo para se obter a lesão hepática.  
Descritores: Cirrose Hepática. Drogas. Tetracloreto de Carbono. Ducto Colédoco. Ratos.
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Introduction
Liver cirrhosis (LC) is considered a public health, 
according to World Health Organization, about 800 thousand 
people die from LC every year. Only in United States LC is 
responsible for around 27 thousand deaths per year, representing 
a mortality rate of 9.2 per 100,000, placing it as the 12th overall 
cause of death1-3.
Nowadays major research centers focus on studying 
LC, its mechanisms and its behavior, complications and possible 
treatments. For that reason it has been developed, efficient 
experimental models of induction of LC in rats.  The two most 
common methods used for experimental LC are the administration 
of carbon tetrachloride (CCl4) and the bile duct ligation (BDL)7-
9. Our aim is to present a comparative study of bile duct ligation 
versus carbon tetrachloride injection for inducing experimental 
liver cirrhosis
Methods
This research was made through Medline/PubMed and 
SciELO web sites looking for papers on the content “induction of 
liver cirrhosis in rats”. We found 107 articles but only 30 from 2004 
to 2011 were selected. The inclusion criteria were: only rats;  bile 
duct ligation and injection of carbon tetrachloride. Histopathologic 
examination for confirming cirrhosis; Time of inducing cirrhosis. 
The exclusion criteria were: large animals cirrhosis; others rodent 
animals; drug inducing cirrhosis such as dimethylnitrosamine; 
thiocetamide; butylhydroperoxide. Others drugs association 
methods: buprenorphine with reduction of portal inflow over a stent 
inserted in the right renal artery; Others methods: unrestricted flow 
using an aortic-portal segment; orthotopic liver transplantation 
with unrestricted portal arterialisation. Thioacetamide associated 
with partial hepatectomy.
Results
The main methods of induction of LC in rats are the 
administration of carbon tetrachloride  and bile duct ligation. 
Below are shown induction of cirrhosis by CCl4, dosage of the 
drug, time for inducing cirrhosis, main test assessment with the 
method and their results (Table 1) and for bile duct ligation (Table 
2).
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Discussion
The main methods of induction of LC in rats are the 
administration of carbon tetrachloride (CCl4)4 and bile duct 
ligation (BDL)11. CCl4 is one of the most used methods nowadays 
however it is considered an extremely toxic method5. Several 
important basic mechanisms of tissue damages induced by CCl4 
have emerged, involving metabolic activation, reactive free radical 
metabolites, lipid peroxidation, covalent binding and disturbance 
of calcium homeostasis. 
The CCl4 administration results in hepatocyte damage, 
necrosis, inflammation, and fibrosis, which spreads to link the 
vascular structures that feed into and drain the hepatic sinusoid (the 
portal tract and central vein radicle, respectively)3,39. It activates 
the hepatic stellate cell (HSC) inducing hepatocyte apoptosis and 
zone III necrosis40. Continuous administration of CCl4 can provide 
moderate cell necrosis and fatty infiltration in four weeks.  
The CCl4 is excreted from the body within the first 24 
hour by conjugation reaction mediated by phase. In the literature, 
three mechanisms have been proposed as the possible explanations 
for progression of injury: (1) Contribution of inflammatory cells; 
(2) Production of free radicals; and (3) Leakage of degradative 
enzymes from the dying and injured cells. Activated resident 
Kupffer cells and the neutrophils recruited at the site of 
parenchymal liver injury are considered as the primary culprits 
in damaging surrounding healthy cells as the result of nonspecific 
action. However, evidence suggests that the contribution of 
the inflammatory cells does not or is not sufficient to mediate 
progression of injury. 
The second theory regarding progression of injury is 
production of free radicals and oxidative stress, and subsequent 
lipid peroxidation that propagates injury. Though the antioxidants 
prevent/delay the tissue damage partially, progression of injury still 
occurs. The inhibition of lipid peroxidation by antioxidants only 
decreases the initial injury of CCl4, blocking lipid peroxidation 
fails to prevent progression of injury and subsequent lethality45. 
By 8 weeks, a micronodular cirrhosis takes place 31.  It has been 
used mainly by intraperitoneal injection12 or oral administration20, 
the dosage 0,2 to 5ml/kg and LC is achieved between 36 hours to 
18 weeks15,20,11,24.
BDL is a safer method comparing to the CCl4. When 
the BDL is done, it provides an acute obstructive jaundice in 
two weeks, and progression to cirrhosis in 4 or 6 weeks9,10. BDL 
stimulates the proliferation of biliary epithelial cells and oval cells 
(which are hepatocyte progenitors), resulting in proliferating bile 
ductules with an accompanying portal inflammation and fibrosis43. 
Cholangiocyte proliferation started after BDL at the edge of 
the portal tract. During the first week from BDL the hepatic 
microcirculation did not show any alterations with respect to the 
normal liver46. Using this method LC is achieved between seven 
days to four weeks17,26.
Conclusions
Based in our broadly review we concluded that LC can 
be induced by CCl4 and BDL, however the manipulation of CCl4 
can be dangerous for the researcher with risk of inducing liver 
tumor. BDL is a safer method than CCl4 and cirrhosis could be 
induced in rats in average mean time of two weeks.
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